Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

NCT00005660 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00005660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
October 31, 1977
Completion date
November 30, 2001
Enrollment
130
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, keratosis palmaris et plantaris, psoriasis